GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.23
Tradestie Score
45
Market Cap
$899.60M
Revenue Growth
0.3%
Analyst Upside
+176.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$12.10
|
$917.23M | - | 52 | Compare |
|
OCS
Oculis Holding AG Ordinary shares
|
$28.07
|
$910.64M | - | 54 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$19.29
|
$906.29M | - | 46 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$49.48
|
$903.54M | - | 61 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$58.34
|
$900.91M | - | 49 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$58.74
|
$894.30M | - | 49 | Compare |
|
ANL
ANL
|
$11.61
|
$892.56M | - | 57 | Compare |
|
EYPT
EyePoint Pharmaceuticals, Inc. Common Stock
|
$11.70
|
$890.20M | - | 51 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$20.63
|
$887.30M | - | 58 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.17
|
$879.90M | 5.1 | 48 | Compare |
More GERN Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry